Hospices Civils de Lyon
Lyon, 69004, France
NCT Number: NCT03768635
The malignant external otitis is a rare disease which arises more frequently at the elderly and the diabetics patients. To our knowledge, there are few data and it is not wellc known byclinicians. Nevertheless it exposes to neurological complications potentially serious and crippling.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Observational
Lyon, 69004, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
description of necrotizing external otitis
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption
description of necrotizing external otitis: patients, profile of the bacterium, medical and chirurgical treatment, rate
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption
Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin. Analyse of risk factor.
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption
Description of the strategies of antibiotic treatments used (double-agent therapy, monotherapy, duration)
Hospices Civils de Lyon
Other
Necrotizing External Otitis : Study in a Regional Bone and Joint Infection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04625478
Bone and Joint Infection, Staphylococcus
Lyon, France
View Trial DetailsNCT04563325
Arthritis, Arthritis, Infectious
Copenhagen, Denmark
View Trial DetailsNCT05248490
Bone and Joint Infection
Boulogne-Billancourt, France
View Trial DetailsNCT03009045
Bone Diseases, Bone Diseases, Infectious
Torrance, California, United States
View Trial Details